An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro (Q35653299)

9 August 2017

An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro (English)

1 reference

9 August 2017

6

E S Vitetta

1 reference

9 August 2017

C McCoig

1

1 reference

9 August 2017

G Van Dyke

2

1 reference

9 August 2017

C S Chou

3

1 reference

9 August 2017

L J Picker

4

1 reference

9 August 2017

O Ramilo

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Proceedings of the National Academy of Sciences of the United States of America

9 August 2017

1 reference

9 August 2017

96

1 reference

9 August 2017

20

1 reference

9 August 2017

11482-11485

1 reference

Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

12 July 2018

HIV-protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Decay characteristics of HIV-1-infected compartments during combination therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Highly purified CD25- resting T cells cannot be infected de novo with HIV-1

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18059

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.96.20.11482

Changes in thymic function with age and during the treatment of HIV infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.96.20.11482

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

21 January 2018

1 reference

12 December 2020

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

1 reference

12 December 2020

The isolation and characterization of the human suppressor inducer T cell subset

1 reference

12 December 2020

Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue

1 reference

12 December 2020

Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1

1 reference

12 December 2020

Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice

1 reference

12 December 2020

Role of CD25+ and CD25-T cells in acute HIV infection in vitro

1 reference

12 December 2020

Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection

1 reference

12 December 2020

Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.96.20.11482

1 reference

9 August 2017

0 references

1 reference

9 August 2017

1 reference